Results 181 to 190 of about 205,027 (361)

Fluid/function correlation using AI‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To investigate the association between best‐corrected visual acuity (BCVA) and quantitative macular fluid volumes, compared to central subfield thickness (CST) in treatment‐naïve and previously treated patients with active neovascular age‐related macular degeneration (nAMD).
Anna Eidenberger   +15 more
wiley   +1 more source

Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

open access: yesNew England Journal of Medicine, 2011
Daniel F. Martin   +5 more
semanticscholar   +1 more source

Consensus on age‐related macular degeneration course curricula for general ophthalmologists and non‐ophthalmologist clinical staff: A Delphi study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To define the curriculum content for two interactive learning courses on age‐related macular degeneration (AMD): (1) an advanced course tailored for general ophthalmologists and (2) a basic course for non‐ophthalmologist healthcare staff.
Filip Sommer‐Lind   +46 more
wiley   +1 more source

Ranibizumab for neovascular age-related macular degeneration.

open access: yesNew England Journal of Medicine, 2006
P. Rosenfeld   +6 more
semanticscholar   +1 more source

Power and clinical utility of mesopic microperimetry analysis strategies in age‐related macular degeneration

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose This study evaluates whether mesopic microperimetry (MMP) provides a more robust measure of retinal function compared to visual acuity (VA) in age‐related macular degeneration (AMD) clinical trials, with a focus on optimal analysis strategies. Method Fellow‐eyes of unilateral neovascular AMD were prospectively studied.
Francesco Cinque   +9 more
wiley   +1 more source

Neovascular age‐related macular degeneration without drusen

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Marc J. Sirks   +9 more
wiley   +1 more source

Targeted Therapy on Age-Related Macular Degeneration

open access: yesTNOA Journal of Ophthalmic Science and Research
Age-related macular degeneration (AMD) is an eye-related condition in developed countries and can affect elderly individuals to lose their central vision.
Vankodoth Sireesha   +4 more
doaj   +1 more source

Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration

open access: bronze, 1999
Christophe Chiquet   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy